CN115074376A - Method for efficiently synthesizing D-psicose by fermentation of recombinant escherichia coli - Google Patents
Method for efficiently synthesizing D-psicose by fermentation of recombinant escherichia coli Download PDFInfo
- Publication number
- CN115074376A CN115074376A CN202210459067.6A CN202210459067A CN115074376A CN 115074376 A CN115074376 A CN 115074376A CN 202210459067 A CN202210459067 A CN 202210459067A CN 115074376 A CN115074376 A CN 115074376A
- Authority
- CN
- China
- Prior art keywords
- psicose
- gene
- coli
- alse
- frua
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 59
- 230000004151 fermentation Effects 0.000 title claims abstract description 58
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 34
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 25
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 15
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 35
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 25
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 claims abstract description 22
- 239000005715 Fructose Substances 0.000 claims abstract description 16
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 15
- 229930091371 Fructose Natural products 0.000 claims abstract description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims abstract description 9
- GSXOAOHZAIYLCY-NGJCXOISSA-N D-psicose 6-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O GSXOAOHZAIYLCY-NGJCXOISSA-N 0.000 claims abstract description 8
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 8
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims abstract description 8
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims abstract description 8
- 239000010452 phosphate Substances 0.000 claims abstract description 8
- 230000004907 flux Effects 0.000 claims abstract description 6
- 230000003834 intracellular effect Effects 0.000 claims abstract description 6
- 229930029653 phosphoenolpyruvate Natural products 0.000 claims abstract description 6
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000758 substrate Substances 0.000 claims abstract description 6
- 238000012546 transfer Methods 0.000 claims abstract description 6
- 241000894006 Bacteria Species 0.000 claims abstract description 4
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000002018 overexpression Effects 0.000 claims abstract description 4
- GSXOAOHZAIYLCY-HSUXUTPPSA-N keto-D-fructose 6-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O GSXOAOHZAIYLCY-HSUXUTPPSA-N 0.000 claims abstract description 3
- 241000252067 Megalops atlanticus Species 0.000 claims description 43
- 101100519658 Mus musculus Pfkm gene Proteins 0.000 claims description 28
- -1 PtsG-F Proteins 0.000 claims description 27
- 101100463616 Mus musculus Pfkl gene Proteins 0.000 claims description 24
- 239000013612 plasmid Substances 0.000 claims description 22
- 238000003786 synthesis reaction Methods 0.000 claims description 13
- 241000579120 Coliiformes Species 0.000 claims description 10
- 241000588722 Escherichia Species 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 230000014509 gene expression Effects 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 7
- 241000948980 Actinobacillus succinogenes Species 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 238000001890 transfection Methods 0.000 claims description 5
- 241001640034 Heteropterys Species 0.000 claims description 4
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 239000007640 basal medium Substances 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 4
- 230000006801 homologous recombination Effects 0.000 claims description 4
- 238000002744 homologous recombination Methods 0.000 claims description 4
- 108700010070 Codon Usage Proteins 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 239000013598 vector Substances 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims 2
- 239000002994 raw material Substances 0.000 claims 2
- 238000003259 recombinant expression Methods 0.000 claims 2
- 239000002028 Biomass Substances 0.000 claims 1
- 241000143940 Colias Species 0.000 claims 1
- XPYBSIWDXQFNMH-UHFFFAOYSA-N D-fructose 1,6-bisphosphate Natural products OP(=O)(O)OCC(O)C(O)C(O)C(=O)COP(O)(O)=O XPYBSIWDXQFNMH-UHFFFAOYSA-N 0.000 claims 1
- RNBGYGVWRKECFJ-ARQDHWQXSA-N beta-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ARQDHWQXSA-N 0.000 claims 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000008929 regeneration Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 238000011161 development Methods 0.000 abstract description 3
- 108091000080 Phosphotransferase Proteins 0.000 abstract description 2
- 230000006860 carbon metabolism Effects 0.000 abstract description 2
- 238000005457 optimization Methods 0.000 abstract description 2
- 102000020233 phosphotransferase Human genes 0.000 abstract description 2
- 230000037361 pathway Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 229940045950 pep-20 Drugs 0.000 description 4
- 239000008057 potassium phosphate buffer Substances 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241000606124 Bacteroides fragilis Species 0.000 description 2
- 102000012435 Phosphofructokinase-1 Human genes 0.000 description 2
- 108010022684 Phosphofructokinase-1 Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- 229940086745 ampicillin 100 mg/ml Drugs 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01004—Fructokinase (2.7.1.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y501/00—Racemaces and epimerases (5.1)
- C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a method for efficiently synthesizing D-psicose by utilizing recombinant escherichia coli fermentation. Uses colibacillus as chassis host bacteria, transfers protein gene by knocking out fructose specificity PTSFruASimultaneous overexpression of fructose non-phosphorylated transporter genepstG‑FFructokinase genemaKD-psicose-6-phosphate epimerase genealsEPsicose-6-phosphate phosphatase genea6PPEstablishing a synthetic pathway from D-fructose to D-psicose; further knock-out of D-fructose-6-phosphate kinase genepfkAAndpfkBregulating and controlling the carbon metabolism flux of the recombinant escherichia coli; overexpression of phosphoenolpyruvate carboxykinaseDue to the fact thatpckAAnd glycerol is used as a carbon source to improve the intracellular ATP concentration. The recombinant escherichia coli constructed by the invention is used for fermentation production, can effectively improve the substrate conversion rate, and provides an optimization scheme for the industrial development of biosynthesis of D-psicose.
Description
Technical Field
The invention belongs to the field of microbial metabolic engineering, and particularly relates to a method for efficiently synthesizing D-psicose by utilizing fermentation of recombinant escherichia coli.
Technical Field
D-psicose is a rare sugar with ultra-low calorie, and the sweetness is 70% of that of sucrose while the energy is only 0.3% of that of sucrose. A large number of researches report that the D-psicose has unique physiological characteristics in the aspects of preventing obesity, treating atherosclerosis, resisting hyperlipidemia, resisting inflammation, resisting oxidation, resisting hyperglycemia, protecting nerves and the like, can improve the gelation state of food, increase the flavor of the food, and even can relieve the oxidation effect in the food processing and storage processes. D-psicose has been approved as a generally recognized as safe product (GRAS) by the Food and Drug Administration (FDA) in the United states, and has great market prospects in the fields of food, beverages, health care and the like.
Since D-psicose is very scarce, development of a method for producing it has attracted considerable attention. The research on the chemical synthesis of D-psicose begins in 1960, but the research has not been broken through in industrial application due to the reasons of more side reactions, complicated purification, serious pollution and the like. In contrast, biosynthesis of D-psicose is highly specific and environmentally friendly. Although the enzyme method has advantages in terms of product conversion rate and product purification, the enzyme production and immobilization are high in cost and long in time, and especially the problem of thermal stability of key enzyme is not completely solved, so that the reusability of the biocatalyst is poor. In contrast, microbial fermentation for the production of D-psicose is an ideal alternative to enzymatic catalysis.
Disclosure of Invention
The present invention has been made in view of the above problems, and an object of the present invention is to provide a method for efficiently synthesizing D-psicose by fermentation using recombinant Escherichia coli. A synthesis path from D-fructose to D-psicose is established in escherichia coli through recombinant vector construction, carbon metabolic flux is reasonably regulated and controlled by means of gene knockout, an ATP intracellular synthesis path is introduced, and efficient synthesis of D-psicose is finally achieved.
In order to achieve the purpose, the invention adopts the following technical scheme:
a method for efficiently synthesizing D-psicose by fermentation of recombinant Escherichia coli inE. coliKnockout of fructose-specific PTS transfer protein Gene in JM109(DE3)fruASimultaneous overexpression of fructose non-phosphorylated transporter geneptsG-FFructokinase genemaKD-psicose-6-phosphate epimerase genealsEAnd psicose-6-phosphate phosphatase genea6PPFour genes are used for constructing a synthetic route of D-psicose; further by knocking out D-fructose-6-phosphate kinase genepfkAAndpfkBblocking the conversion of intracellular fructose-6-phosphate into fructose-1, 6-diphosphate, and leading the carbon flux of D-fructose to enter a product synthesis way to the maximum extent; reintroducing a heterologous phosphoenolpyruvate carboxykinase genepckAUsed for expressing PckA protein and realizing the intracellular circulation of ATP; and finally, performing oxygen-limited fermentation by using an M9 basal medium containing glycerol as a fermentation medium of the recombinant escherichia coli to realize the high-efficiency synthesis of the D-psicose.
The method for efficiently synthesizing the D-psicose by utilizing the recombinant escherichia coli fermentation specifically comprises the following steps:
(1) knock-outE. coliFructose-specific PTS transfer protein Gene of JM109(DE3)fruAAnd overexpressing a fructose non-phosphorylated transporter geneptsG-FFructokinase genemaKD-psicose-6-phosphate epimerase genealsEAnd psicose-6-phosphate phosphatase genea6PPFour genes to obtainE. coli(Δ FruA, PtsG-F, MaK, AlsE, A6 PP);
(2) in bacterial strainsE. coli(Δ FruA, PtsG-F, MaK, AlsE, A6PP) knock-out of D-fructose-6-phosphokinase GenepfkAAndpfkBto obtainE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6 PP);
(3) in bacterial strainsE. coli (delta FruA, delta PfkA, delta PfkB, PtsG-F, MaK, AlsE, A6PP) based on the expression of phosphoenolpyruvate carboxykinase GenepckAObtaining recombinant Escherichia coliE. coli (ΔFruA, ΔPfkA, ΔPfkB, PtsG-F, MaK, AlsE, A6PP, PckA);
(4) Fermentation culture using M9 minimal medium containing glycerolE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) strain.
The specific process of the step (1) is as follows: use of primersfruAF (SEQ ID number 1) andfruAPCR amplification of R (SEQ ID number 2) using pKD13 plasmid as template, followed by transfection of the PCR product into a plasmid containing pKD46E. coliJM109(DE3) was subjected to homologous recombination, single colony was picked for activation and competent cells were prepared, transfected with pep 20 plasmid, cultured overnight in a shaker at 30 ℃ and 220 rpm to eliminate resistance marker, and finally the pep 20 plasmid was lost under the culture conditions at 42 ℃ and 220 rpm to obtainE. coli(Δ FruA) strain; then artificially synthesized pETDuet-ptsG-F-maKAnd pRSFDuet-alsE-a6PPTransfection of recombinant plasmids intoE. coli(. DELTA.FruA) to giveE. coli(Δ FruA, PtsG-F, MaK, AlsE, A6 PP); wherein the content of the first and second substances,ptsG-F、maK、alsEanda6PPthe gene sequence of (A) is shown in SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO. 6.
The specific process of the step (2) is as follows: use of primerspfkA-F/pfkA-R andpfkB-F/pfkB-R is knocked out according to the method in step (1)pfkAAndpfkBgene, obtainingE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6 PP); wherein the content of the first and second substances,pfkA-F andpfkAthe-R primer sequences are respectively shown as SEQ ID NO.7 and SEQ ID NO.8,pfkB-F andpfkBthe-R primer sequences are respectively shown as SEQ ID NO.9 and SEQ ID NO. 10.
The specific process of the step (3) is as follows: actinobacillus succinogenes: (Actinobacillus succinogenes) Of originpckAThe gene is artificially synthesized (SEQ ID NO. 11) after being optimized according to the codon preference of escherichia coli, and the gene is used as a templateUsing a primerpckAF (SEQ ID NO. 12) andpckAr (SEQ ID NO. 13) for PCR amplification using Xho I and Avr II for insertion of the gene fragment pRSFDuet-alsE-a6PPObtaining the recombinant vector pRSFDuet-alsE-a6PP- pckATransfection ofE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP) to yield recombinant E.coliE. coli (ΔFruA, ΔPfkA, ΔPfkB, PtsG-F, MaK, AlsE, A6PP, PckA)。
The specific process of the step (4) is as follows: fermentation culture using M9 basal mediumE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) strain to which 8 g/L of glycerol was added as a carbon source for cell growth, 2.2 g/L D-fructose was added as a substrate for synthesis of D-psicose, protein expression was induced using 0.1 mM IPTG, and the bottle mouth was blocked with a rubber plug during fermentation.
The application of the method for efficiently synthesizing the D-psicose by utilizing the recombinant escherichia coli fermentation in the production of the D-psicose is disclosed.
Compared with the prior art, the invention has the following beneficial effects: compared with the existing enzyme catalysis method, the method has the advantages of simpler operation and larger reaction scale, and effectively solves the problem of high cost caused by enzyme reutilization and immobilization. Compared with the existing fermentation method based on the reversible epimerization synthesis path, the substrate conversion rate of the D-psicose synthesis path is obviously improved, and an optimization scheme is provided for the industrial development of the D-psicose synthesis method by the fermentation method.
Drawings
FIG. 1 shows recombinant Escherichia coliE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) metabolism scheme for the synthesis of D-psicose.
FIG. 2 is the recombinant plasmid pETDuet-ptsG-F-maKAnd pRSFDuet-alsE-a6PPA map of (a). A: pETDuet-ptsG-F-maK;B:pRSFDuet-alsE-a6PP。
FIG. 3 is a drawing showingE. coli (Δ FruA, PtsG-F, MaK, AlsE, A6 PP). A: adding 4 g/L of LB culture mediumD-fructose fermentation results; b: the fermentation result was obtained by adding 4 g/L D-fructose to LB medium and adding 50 mM potassium phosphate buffer.
FIG. 4 shows fermentation results after knocking out PfkA and PfkB. A:E. coli (Δ FruA, Δ PfkA, PtsG-F, MaK, AlsE, A6PP) strain; b:E. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6 PP).
FIG. 5 shows the recombinant plasmid pRSFDuet-alsE-a6PP-pckAA map of (a).
FIG. 6 shows recombinant Escherichia coliE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP, PckA).
FIG. 7 shows recombinant Escherichia coliE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) fermentation results in M9 medium supplemented with 8 g/L of glycerol and 2.2 g/L D-fructose.
Detailed Description
The present invention is further illustrated by the following examples, which are intended to be illustrative only and not limiting.
Recombinant Escherichia coli in the present inventionE. coli The metabolic scheme for the synthesis of D-psicose (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) is shown in FIG. 1.
Example 1
Host bacteria in the underpanE. coliKnockout of fructose-specific PTS transfer protein gene based on JM109(DE3)fruAUsing a primerfruAF (SEQ ID NO. 1) andfruA-R (SEQ ID NO. 2) was PCR-amplified using pKD13 plasmid as a template, and the amplification product was transfected into a plasmid containing pKD46E. coliJM109(DE3) was subjected to homologous recombination, single colony activation and competent cell preparation were picked, transfected with pep 20 plasmid, cultured overnight at 30 ℃ and 220 rpm in a shaker to eliminate the resistance marker, and finally the pep 20 plasmid was lost under 42 ℃ and 220 rpm culture conditions to obtain a recombinant plasmidE. coli(Δ FruA) strain. The fructose non-phosphorylated transporter geneptsG-FFructokinase genemaKInsert pRSFDuet-1 to obtain pETDuet-ptsG-F-maKRecombinant plasmid(plasmid map see FIG. 2A). The D-psicose-6-phosphate epimerase genealsEAnd psicose-6-phosphate phosphatase genea6PPpRSFDuet-1 was inserted to obtain pRSFDuet-alsE-a6PPRecombinant plasmid (plasmid map see FIG. 2B). Wherein the fructose non-phosphorylated transporter geneptsG-FFructokinase genemaKD-psicose-6-phosphate epimerase genealsEAnd psicose-6-phosphate phosphatase genea6PPThe gene sequences of the gene are respectively shown in SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO.6,ptsG-Fthe gene is Escherichia coliE. coliJM109(DE3)ptsGThe 34 th nucleotide of the gene is mutated from G to T,maKandalsEthe gene is Escherichia coliE. coliOverexpression of JM109(DE3) own gene,a6PPthe gene is derived from bacteroides fragilis (B.), (Bacteroides fragilis) (ii) a In the present invention, a fructose non-phosphorylated transporter geneptsG-FFructokinase genemaKD-psicose-6-phosphate epimerase genealsEAnd psicose-6-phosphate phosphatase genea6PPAre all artificially synthesized. Artificially synthesized pETDuet-ptsG-F-maKAnd pRSFDuet-alsE-a6PPTransfection of recombinant plasmids intoE. coli(. DELTA.FruA) to giveE. coli(Δ FruA, PtsG-F, MaK, AlsE, A6 PP).
Will be provided withE. coli(Δ FruA, PtsG-F, MaK, AlsE, A6PP) Strain was activated overnight, inoculated to 50 mL of LB liquid medium containing 4 g/L D-fructose at an inoculum size of 1%, ampicillin was added thereto at a final concentration of 100 mg/mL and kanamycin was added thereto at a final concentration of 50 mg/mL, and fermentation-cultured in a shaker at 37 ℃ and 220 rpm for 72 hours, protein expression was induced by addition of 0.1 mM IPTG at a final concentration after 3 hours of fermentation culture, and sampling was performed at 12-hour intervals during fermentation culture using a preparation equipped with Sugar-Pak TM Measuring the content of D-fructose and the content of D-psicose in fermentation liquor by using a high performance liquid chromatograph (Chromaster HPLC, HITACHI) of an I (6.5 × 300 mm, 85, Waters) chromatographic column and a differential refraction detector (RID), wherein the mobile phase is deionized water, the flow rate is 0.5 mL/min, the column temperature is 85 ℃, the detector temperature is 55 ℃, and the sample injection amount is 20 muL. The results are shown in FIG. 3A, where the cells were in the course of fermentationMedium growth, weak ability and final OD of fermentation broth 600 Only about 0.5, probably because the pH of the fermentation liquor is reduced due to the dephosphorylation reaction, the cell growth is influenced, and the pH of the final fermentation liquor is measured by a pH meter, and the measured pH value is about 3.9; however, D-psicose was apparently produced in the fermentation broth at a yield of 0.351 g/L and a yield of 0.159 g/g.
Will be provided withE. coli(Δ FruA, PtsG-F, MaK, AlsE, A6PP) strains were activated overnight, transferred to 50 mL of LB broth containing 4 g/L D-fructose in 1% inoculum size, added to the medium with a final concentration of 50 mM potassium phosphate buffer (purchased from a source leaf organism, cat # R26329) to adjust the pH, added with a final concentration of 100 mg/mL ampicillin and a final concentration of 50 mg/mL kanamycin, fermentatively cultured in a shaker at 37 ℃ and 220 rpm for 72 hours, added with a final concentration of 0.1 mM IPTG after 3 hours of fermentation culture to induce protein expression, sampled every 12 hours during fermentation culture, and prepared with Sugar-Pak TM Measuring the content of D-fructose and the content of D-psicose in fermentation liquor by using a high performance liquid chromatograph (Chromaster HPLC, HITACHI) of an I (6.5 × 300 mm, 85, Waters) chromatographic column and a differential refraction detector (RID), wherein the mobile phase is deionized water, the flow rate is 0.5 mL/min, the column temperature is 85 ℃, the detector temperature is 55 ℃, and the sample injection amount is 20 muL. The results are shown in FIG. 3B, where cell growth is alleviated and the final OD of the fermentation broth 600 About 2.4 was achieved, and the D-psicose production was increased to 0.510 g/L.
Example 2
The strains obtained in example 1E. coli(Δ FruA, PtsG-F, MaK, AlsE, A6PP) based on the knockout method in example 1 using the corresponding knockout primerpfkA-F andpfkA-R knockout of 6-phosphofructokinase GenepfkATo obtainE. coli(Δ FruA, Δ PfkA, PtsG-F, MaK, AlsE, A6 PP). In bacterial strainsE. coli(Δ FruA, Δ PfkA, PtsG-F, MaK, AlsE, A6PP) based on the knockout method in example 1 using the corresponding knockout primerspfkB-F andpfkB-R knockout of 6-phosphofructokinase GenepfkBTo regulate the carbon metabolism flux of D-fructose to obtainE. coli (ΔFruA, ΔPfkA, ΔPfkB, PtsG-F, MaK, AlsE, A6PP)And (3) strain.pfkA-F andpfkAthe-R primer sequences are shown as SEQ ID NO.7 and SEQ ID NO. 8.pfkB-F andpfkBthe-R primer sequences are shown as SEQ ID NO.9 and SEQ ID NO. 10.
The strain was fermentatively cultured as in example 1. The strain was activated overnight, transferred to 50 mL of LB liquid medium containing 4 g/L D-fructose at an inoculum size of 1%, to the medium was added 50 mM potassium phosphate buffer (purchased from a source leaf organism, cat # R26329) to adjust pH, to which was added ampicillin 100 mg/mL to a final concentration and kanamycin 50 mg/mL to a final concentration, and fermentation-cultured for 72 hours at 37 ℃ and 220 rpm in a shaker, and after 3 hours of fermentation-culture, protein expression was induced by adding IPTG 0.1 mM to a final concentration, and sampling was performed every 12 hours during the fermentation-culture using a device equipped with Sugar-Pak TM Measuring the content of D-fructose and the content of D-psicose in fermentation liquor by using a high performance liquid chromatograph (Chromaster HPLC, HITACHI) of an I (6.5 × 300 mm, 85, Waters) chromatographic column and a differential refraction detector (RID), wherein the mobile phase is deionized water, the flow rate is 0.5 mL/min, the column temperature is 85 ℃, the detector temperature is 55 ℃, and the sample injection amount is 20 muL. The results are shown in FIG. 4, FIG. 4AE. coli (Δ FruA, Δ PfkA, PtsG-F, MaK, AlsE, A6PP) produced 0.721 g/L D-psicose in a yield of 0.180 g/g after 72 h of strain; in FIG. 4BE. coli The yield and yield of the (delta FruA, delta PfkA, delta PfkB, PtsG-F, MaK, AlsE and A6PP) strain are obviously improved and are respectively 0.816 g/L and 0.614 g/g, which shows that the reasonable limitation of the carbon metabolic flux of D-fructose is beneficial to the efficient conversion of synthetic reaction.
Example 3
Actinobacillus succinogenes: (Actinobacillus succinogenes) Phosphoenolpyruvate carboxykinase gene frompckAIs synthesized artificially after being optimized according to the codon preference of the escherichia coli, and the synthesized template sequence is SEQ ID NO. 11. Use of primerspckAF (SEQ ID NO. 12) andpckA-R (SEQ ID NO. 13) is artificially synthesizedpckAAfter PCR amplification of the template, the gene fragment was inserted into pRSFDuet-alsE-a6PPThen, pRSFDuet-alsE-a6PP-pckARecombinant plasmid (plasmid map is shown in FIG. 5), then transfected intoE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP) to obtain recombinant Escherichia coliE. coli (ΔFruA, ΔPfkA, ΔPfkB, PtsG-F, MaK, AlsE, A6PP, PckA)。
The strain was fermentatively cultured as in example 1. The strain was activated overnight, transferred to 50 mL of LB liquid medium containing 4 g/L D-fructose at an inoculum size of 1%, to the medium was added 50 mM potassium phosphate buffer (purchased from a source leaf organism, cat # R26329) to adjust pH at a final concentration, to which was added ampicillin at a final concentration of 100 mg/mL and kanamycin at a final concentration of 50 mg/mL, and subjected to fermentation culture at 37 ℃ for 72 hours in a shaker at 220 rpm, and after 3 hours of fermentation culture, protein expression was induced by the addition of IPTG at a final concentration of 0.1 mM, and sampling was performed every 12 hours during the fermentation culture. During the fermentation culture, the bottle mouth is sealed by using a rubber plug, and an inducer is added or a sample is taken by an injector. Using a belt-Pak TM Measuring the content of D-fructose and the content of D-psicose in fermentation liquor by using a high performance liquid chromatograph (Chromaster HPLC, HITACHI) of an I (6.5 × 300 mm, 85, Waters) chromatographic column and a differential refraction detector (RID), wherein the mobile phase is deionized water, the flow rate is 0.5 mL/min, the column temperature is 85 ℃, the detector temperature is 55 ℃, and the sample injection amount is 20 muL. Fermentation experiments were carried out using the fermentation media referred to in example 1, the results are shown in FIG. 6, strainE. coli The yield of D-psicose in the fermentation broth (delta FruA, delta PfkA, delta PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) was further increased to about 1.23 g/L, and the yield was about 0.683 g/g.
Example 4
In this example, the oxygen-limited fermentation experiments were performed on M9 minimal medium. Bacterial strainsE. coli (Δ FruA,. DELTA.PfkA,. DELTA.PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) was activated overnight, transferred to M9 basal medium at an inoculum size of 1%, to which 8 g/L of glycerol and 2.2 g/L D-fructose were added together with ampicillin at a final concentration of 100 mg/mL and kanamycin at a final concentration of 50 mg/mL, and subjected to fermentation culture at 37 ℃ for 96 hours at 220 rpm in a shaker, and after 3 hours of fermentation culture, protein expression was induced by the addition of IPTG at a final concentration of 0.1 mM, and sampling was carried out at 20-hour intervals during the fermentation culture. During the fermentation culture, the bottle mouth of the culture bottle is sealed by using a rubber plug, and an inducer is added or a sample is taken by an injector. The results are shown in FIG. 7, 2.2 g/LD-fructose was completely converted into D-psicose (1.590 g/L) after 96 h, with a yield of about 0.722 g/g.
SEQUENCE LISTING
<110> Fuzhou university, Qingyuan innovation laboratory
<120> method for efficiently synthesizing D-psicose by utilizing recombinant escherichia coli fermentation
<130>
<160> 13
<170> PatentIn version 3.3
<210> 1
<211> 70
<212> DNA
<213> Artificial sequence
<400> 1
ctgacagcag gagaggcata atgaaaacgc tgctgattat tgacgctaat attccgggga 60
tccgtcgacc 70
<210> 2
<211> 71
<212> DNA
<213> Artificial sequence
<400> 2
gccctgtaac acacctttta ttacgctgct ttcgctactg cgtccacttc gtgtaggctg 60
gagctgcttc g 71
<210> 3
<211> 1434
<212> DNA
<213> Artificial sequence
<400> 3
atgtttaaga atgcatttgc taacctgcaa aagttcggta aatcgctgat gctgccggta 60
tccgtactgc ctatcgcagg tattctgctg ggcgtcggtt ccgcgaattt cagctggctg 120
cccgccgttg tatcgcatgt tatggcagaa gcaggcggtt ccgtctttgc aaacatgcca 180
ctgatttttg cgatcggtgt cgccctcggc tttaccaata acgatggcgt atccgcgctg 240
gccgcagttg ttgcctatgg catcatggtt aaaaccatgg ccgtggttgc gccactggta 300
ctgcatttac ctgctgaaga aatcgcctct aaacacctgg cggatactgg cgtactcgga 360
gggattatct ccggtgcgat cgcagcgtac atgtttaacc gtttctaccg tattaagctg 420
cctgagtatc ttggcttctt tgccggtaaa cgctttgtgc cgatcatttc tggcctggct 480
gccatcttta ctggcgttgt gctgtccttc atttggccgc cgattggttc tgcaatccag 540
accttctctc agtgggctgc ttaccagaac ccggtagttg cgtttggcat ttacggtttc 600
atcgaacgtt gcctggtacc gtttggtctg caccacatct ggaacgtacc tttccagatg 660
cagattggtg aatacaccaa cgcagcaggt caggttttcc acggcgacat tccgcgttat 720
atggcgggtg acccgactgc gggtaaactg tctggtggct tcctgttcaa aatgtacggt 780
ctgccagctg ccgcaattgc tatctggcac tctgctaaac cagaaaaccg cgcgaaagtg 840
ggcggtatta tgatctccgc ggcgctgacc tcgttcctga ccggtatcac cgagccgatc 900
gagttctcct tcatgttcgt tgcgccgatc ctgtacatca tccacgcgat tctggcaggc 960
ctggcattcc caatctgtat tcttctgggg atgcgtgacg gtacgtcgtt ctcgcacggt 1020
ctgatcgact tcatcgttct gtctggtaac agcagcaaac tgtggctgtt cccgatcgtc 1080
ggtatcggtt atgcgattgt ttactacacc atcttccgcg tgctgattaa agcactggat 1140
ctgaaaacgc cgggtcgtga agacgcgact gaagatgcaa aagcgacagg taccagcgaa 1200
atggcaccgg ctctggttgc tgcatttggt ggtaaagaaa acattactaa cctcgacgca 1260
tgtattaccc gtctgcgcgt cagcgttgct gatgtgtcta aagtggatca ggccggcctg 1320
aagaaactgg gcgcagcggg cgtagtggtt gctggttctg gtgttcaggc gattttcggt 1380
actaaatccg ataacctgaa aaccgagatg gatgagtaca tccgtaacca ctaa 1434
<210> 4
<211> 909
<212> DNA
<213> Artificial sequence
<400> 4
gtgcgtatag gtatcgattt aggcggcacc aaaactgaag tgattgcact gggcgatgca 60
ggggagcagt tgtaccgcca tcgtctgccc acgccgcgtg atgattaccg gcagactatt 120
gaaacgatcg ccacgttggt tgatatggcg gagcaggcga cggggcagcg cggaacggta 180
ggtatgggca ttcctggctc aatttcgcct tacaccggtg tggtgaagaa tgccaattca 240
acctggctca acggtcagcc attcgataaa gacttaagcg cgaggttgca gcgggaagtg 300
cggctggcaa atgacgctaa ctgtctggcg gtttcagaag cagtagatgg cgcggcagcg 360
ggagcgcaga cggtatttgc cgtgattatc ggcacgggat gcggcgcggg cgtggcattc 420
aatgggcggg cgcatatcgg cggcaatggc acggcaggtg agtggggaca caatccgcta 480
ccgtggatgg acgaagacga actgcgttat cgcgaggaag tcccttgtta ttgcggtaaa 540
caaggttgta ttgaaacctt tatttcgggc acgggattcg cgatggatta tcgtcgtttg 600
agcggacatg cgctgaaagg cagtgaaatt atccgcctgg ttgaagaaag cgatccggta 660
gcggaactgg cattgcgtcg ctacgagctg cggctggcaa aatcgctggc acatgtcgtg 720
aatattctcg atccggatgt gattgtcctg gggggcggga tgagcaatgt agaccgttta 780
tatcaaacgg ttgggcagtt gattaaacaa tttgtcttcg gcggcgaatg tgaaacgccg 840
gtgcgtaagg cgaagcacgg tgattccagc ggcgtacgcg gcgctgcgtg gttatggcca 900
caagagtaa 909
<210> 5
<211> 696
<212> DNA
<213> Artificial sequence
<400> 5
atgaaaatct ccccctcgtt aatgtgtatg gatctgctga aatttaaaga acagatcgaa 60
tttatcgaca gccatgccga ttacttccac atcgatatca tggacggtca ctttgtcccc 120
aatctgacac tctcaccgtt cttcgtaagt caggttaaaa aactggcaac taaaccgctc 180
gactgtcatc tgatggtgac gcggccgcag gattacattg ctcaactggc gcgtgcggga 240
gcagatttca tcactctgca tccggaaacc atcaacggcc aggcgttccg cctgattgat 300
gaaatccgcc gtcatgacat gaaagtgggg ctgatcctta acccggagac gccagttgag 360
gccatgaaat actatatcca taaggccgat aaaattacgg tcatgactgt cgatcccggc 420
tttgccggac aaccgttcat tcctgaaatg ctggataaac ttgccgaact gaaggcatgg 480
cgtgaacgag aaggtctgga gtacgaaatt gaggtggacg gttcctgcaa ccaggcaact 540
tacgaaaaac tgatggcggc aggggcggat gtctttatcg tcggcacttc cggcctgttt 600
aatcatgcgg aaaatatcga cgaagcatgg agaattatga ccgcgcagat tctggctgca 660
aaaagcgagg tacagcctca tgcaaaaaca gcataa 696
<210> 6
<211> 669
<212> DNA
<213> Artificial sequence
<400> 6
atgaaataca ctgtttattt attcgacttt gactatacac tggcagactc ttcgcgtggc 60
atcgtaacct gcttcagaag cgtactcgag agacatggct acaccggtat cactgatgat 120
atgatcaaac gcaccattgg gaaaacgctt gaagaatcgt tcagcatcct tacgggaatt 180
actgacgccg accaactgga atcattcaga caagagtatt ccaaagaggc agatatatac 240
atgaatgcaa ataccattct tttcccggat actctcccca cgcttacaca cctgaaaaaa 300
cagggaatcc gtatcggaat catttcaacc aaataccgat tccggatact gagtttcctg 360
agaaatcaca tgccggatga ttggtttgac atcattatcg gaggtgaaga tgtgacacat 420
cataaacccg atcctgaagg tttgctactt gccatcgacc gattgaaggc atgccccgaa 480
gaagtattat acatcggtga cagtacagtg gatgcaggaa cagccgccgc tgccggagtt 540
tcttttaccg gtgttaccag cggtatgact actgcccaag agtttcaggc ctatccctac 600
gacagaatca tcagtactct tggccagcta atctccgttc cggaagacaa atccggctgt 660
ccgctctga 669
<210> 7
<211> 71
<212> DNA
<213> Artificial sequence
<400> 7
atgattaaga aaatcggtgt gttgacaagc ggcggtgatg cgccaggcat gtgtaggctg 60
gagctgcttc g 71
<210> 8
<211> 70
<212> DNA
<213> Artificial sequence
<400> 8
ttaatacagt tttttcgcgc agtccagcca gtcacctttg aacggacgct attccgggga 60
tccgtcgacc 70
<210> 9
<211> 71
<212> DNA
<213> Artificial sequence
<400> 9
atggtacgta tctatacgtt gacacttgcg ccctctctcg atagcgcaac gtgtaggctg 60
gagctgcttc g 71
<210> 10
<211> 70
<212> DNA
<213> Artificial sequence
<400> 10
ttagcgggaa aggtaagcgt aaattttttg cgtatcgtca tgggagcaca attccgggga 60
tccgtcgacc 70
<210> 11
<211> 696
<212> DNA
<213> Artificial sequence
<400> 11
atgaaaatct ccccctcgtt aatgtgtatg gatctgctga aatttaaaga acagatcgaa 60
tttatcgaca gccatgccga ttacttccac atcgatatca tggacggtca ctttgtcccc 120
aatctgacac tctcaccgtt cttcgtaagt caggttaaaa aactggcaac taaaccgctc 180
gactgtcatc tgatggtgac gcggccgcag gattacattg ctcaactggc gcgtgcggga 240
gcagatttca tcactctgca tccggaaacc atcaacggcc aggcgttccg cctgattgat 300
gaaatccgcc gtcatgacat gaaagtgggg ctgatcctta acccggagac gccagttgag 360
gccatgaaat actatatcca taaggccgat aaaattacgg tcatgactgt cgatcccggc 420
tttgccggac aaccgttcat tcctgaaatg ctggataaac ttgccgaact gaaggcatgg 480
cgtgaacgag aaggtctgga gtacgaaatt gaggtggacg gttcctgcaa ccaggcaact 540
tacgaaaaac tgatggcggc aggggcggat gtctttatcg tcggcacttc cggcctgttt 600
aatcatgcgg aaaatatcga cgaagcatgg agaattatga ccgcgcagat tctggctgca 660
aaaagcgagg tacagcctca tgcaaaaaca gcataa 696
<210> 12
<211> 45
<212> DNA
<213> Artificial sequence
<400> 12
ccgctcgaga aggagatgaa aatctccccc tcgttaatgt gtatg 45
<210> 13
<211> 31
<212> DNA
<213> Artificial sequence
<400> 13
ccccatggtt agtggttacg gatgtactca t 31
Claims (7)
1. High-efficiency fermentation agent by utilizing recombinant escherichia coliA process for the formation of D-psicose, characterized in that: to be provided withE.coliJM109(DE3) is a chassis host bacterium, and fructose specific PTS transfer protein gene is knocked outfruAAnd overexpresses the fructose non-phosphorylated transporter geneptsG-FFructokinase genemaKD-psicose-6-phosphate epimerase genealsEAnd psicose-6-phosphate phosphatase genea6PPFour genes establishing a biosynthetic pathway from D-fructose to D-psicose; further knocking out D-fructose-6-phosphokinase genepfkAAndpfkBthe reasonable regulation and control of the carbon flux of the D-fructose is realized; overexpression of phosphoenolpyruvate carboxykinase GenepckATo increase intracellular ATP concentration; and finally, supplying the D-fructose serving as a substrate raw material and glycerol serving as a carbon source for oxygen-limited fermentation, thereby ensuring the efficient conversion of the D-psicose.
2. The method for efficiently synthesizing D-psicose by fermentation of recombinant Escherichia coli according to claim 1, comprising the following steps:
(1) to be provided withE. coliJM109(DE3) is a chassis host bacterium, and homologous recombination technology is used for knocking out fructose specific PTS transfer protein genefruAAnd overexpressing a fructose non-phosphorylated transporter geneptsG-FFructokinase genemaKD-psicose-6-phosphate epimerase genealsEAnd psicose-6-phosphate phosphatase genea6PPFour genes to obtainE. coli(Δ FruA, PtsG-F, MaK, AlsE, A6 PP);
(2) in bacterial strainsE. coli(delta FruA, PtsG-F, MaK, AlsE, A6PP) and knocking out D-fructose-6-phosphokinase gene by using homologous recombination technologypfkAAndpfkBto block the conversion of D-fructose-6-phosphate to D-fructose-1, 6-diphosphate to obtainE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6 PP);
(3) in bacterial strainsE. coli (delta FruA, delta PfkA, delta PfkB, PtsG-F, MaK, AlsE, A6PP) based on the expression of phosphoenolpyruvate carboxykinase genespckASo as to realize the intracellular cyclic regeneration of ATP and obtain the recombinant escherichia coliE. coli (ΔFruA, ΔPfkA, ΔPfkB, PtsG-F, MaK, AlsE, A6PP, PckA);
(4) The strain is inoculated by using D-fructose as a substrate raw material, glycerol as a carbon source and an M9 basic culture mediumE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) to enhance oxygen-limited fermentationE. coli (Δ FruA,. DELTA.PfkA,. DELTA.PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) and increased biomass in the fermentation broth.
3. The method for efficiently synthesizing D-psicose by fermentation using recombinant Escherichia coli according to claim 2, wherein: the specific process of the step (1) is as follows: using pKD13 plasmid as a template and primersfruA-F andfruAPCR amplification of-R, transfection of the amplification product into a plasmid containing pKD46 by electrochemical transformationE. coliJM109(DE3) was recombined and the resistance marker was knocked out using the pcp20 plasmid to obtainE. coli(Δ FruA) strain, wherein,fruA-F andfruA-R primer sequences are respectively shown as SEQ ID NO.1 and SEQ ID NO. 2; artificial synthesis of pETDuet-ptsG-F-maKAnd pRSFDuet-alsE-a6PPRecombinant expression vector, transfected intoE. coli(. DELTA.FruA) to giveE. coli(Δ FruA, PtsG-F, MaK, AlsE, A6PP) strain, wherein,ptsG-F、maK、alsEanda6PPthe gene sequences of (A) are respectively shown in SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO. 6.
4. The method for efficiently synthesizing D-psicose by fermentation using recombinant Escherichia coli according to claim 2, wherein: the specific process of the step (2) is as follows: use of primerspfkA-F/pfkA-R andpfkB-F/pfkB-R is knocked out according to the method in step (1)pfkAAndpfkBgene, obtainingE. coli (Δ FruA,. DELTA.PfkA,. DELTA.PfkB, PtsG-F, MaK, AlsE, A6PP) strain, wherein,pfkA-F andpfkAthe-R primer sequences are respectively shown as SEQ ID number 7 and SEQ ID number 8,pfkB-F andpfkBthe-R primer sequences are respectively shown as SEQ ID NO.9 and SEQ ID NO.10。
5. The method for efficiently synthesizing D-psicose by fermentation using recombinant Escherichia coli according to claim 2, wherein: the specific process of the step (3) is as follows: actinobacillus succinogenes: (Actinobacillus succinogenes) Of originpckAThe gene is artificially synthesized after being optimized according to codon preference of escherichia coli, and primers are usedpckA-F andpckA-R is amplified by means of two enzymatic cleavage sites Xho I and Avr IIpckAGene insertion pRSFDuet-alsE-a6PPRecombinant expression vector to obtain the recombinant vector pRSFDuet-alsE-a6PP-pckAAnd then transfected intoE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP) to obtain recombinant Escherichia coliE. coli (Δ FruA, Δ PfkA, Δ PfkB, PtsG-F, MaK, AlsE, A6PP, PckA), whereinpckAThe gene sequence is shown in SEQ ID NO.11,pckA-F andpckAthe-R primer sequences are respectively shown as SEQ ID NO.12 and SEQ ID NO. 13.
6. The method for efficiently synthesizing D-psicose by fermentation using recombinant Escherichia coli according to claim 2, wherein: the specific process of the step (4) is as follows: fermentation culture using M9 basal mediumE. coli (Δ FruA,. DELTA.PfkA,. DELTA.PfkB, PtsG-F, MaK, AlsE, A6PP, PckA) strain to which 8 g/L of glycerol was added as a carbon source for cell growth, 2.2 g/L D-fructose was added as a substrate for synthesis of D-psicose, protein expression was induced using 0.1 mM IPTG, and the mouth of the bottle was closed with a rubber plug during fermentation.
7. Use of the method for efficiently synthesizing D-psicose by fermentation of recombinant Escherichia coli according to claim 1 for producing D-psicose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210459067.6A CN115074376B (en) | 2022-04-28 | 2022-04-28 | Method for efficiently synthesizing D-psicose by utilizing recombinant escherichia coli fermentation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210459067.6A CN115074376B (en) | 2022-04-28 | 2022-04-28 | Method for efficiently synthesizing D-psicose by utilizing recombinant escherichia coli fermentation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115074376A true CN115074376A (en) | 2022-09-20 |
CN115074376B CN115074376B (en) | 2023-11-14 |
Family
ID=83248121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210459067.6A Active CN115074376B (en) | 2022-04-28 | 2022-04-28 | Method for efficiently synthesizing D-psicose by utilizing recombinant escherichia coli fermentation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115074376B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115976134A (en) * | 2022-10-21 | 2023-04-18 | 福州大学 | Method for realizing efficient synthesis of D-psicose by temperature-controlled fermentation of recombinant escherichia coli based on confinement effect |
CN116042684A (en) * | 2023-01-30 | 2023-05-02 | 态创生物科技(广州)有限公司 | Coli and application thereof in catalytic synthesis of psicose |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110041910A (en) * | 2009-10-16 | 2011-04-22 | 경상대학교산학협력단 | A echerichia coli comprising a polynucleotide encoding psicose 3-epimerase and method of producing psicose using the same |
WO2017002978A1 (en) * | 2015-07-02 | 2017-01-05 | 協和発酵バイオ株式会社 | Method for producing rare sugar |
US20170298400A1 (en) * | 2014-10-01 | 2017-10-19 | Industry-Academic Cooperation Foundation Gyeongsang National University | Method for producing psicose |
CN107723307A (en) * | 2017-10-09 | 2018-02-23 | 中国科学院天津工业生物技术研究所 | A kind of method and its application for efficiently preparing the epimerase of D psicoses 3 |
US20180273994A1 (en) * | 2014-11-06 | 2018-09-27 | Industry-Academic Cooperation Foundation Gyeongsang National University | Method for preparing psicose |
WO2019144944A1 (en) * | 2018-01-25 | 2019-08-01 | 中国科学院天津工业生物技术研究所 | Engineering strain for producing psicose and derivatives thereof, construction method therefor and application thereof |
CN112080453A (en) * | 2020-08-28 | 2020-12-15 | 天津科技大学 | Genetic engineering bacterium for synthesizing D-psicose and construction method and application thereof |
CN112501224A (en) * | 2020-11-26 | 2021-03-16 | 北京化工大学 | Method for biosynthesizing D-allose by using D-glucose |
CN113005132A (en) * | 2021-03-12 | 2021-06-22 | 江南大学 | New sourced D-psicose-3-epimerase gene and application method thereof |
CN113474463A (en) * | 2019-03-01 | 2021-10-01 | 科汉森母乳低聚糖股份有限公司 | Fermentative production of carbohydrates by using microbial cells that mix raw materials |
CN113801833A (en) * | 2021-09-08 | 2021-12-17 | 福州大学 | Recombinant bacterium single-cell factory for producing D-psicose and construction and application thereof |
CN114350727A (en) * | 2022-01-18 | 2022-04-15 | 广西大学 | Method for synthesizing D-psicose by combining phosphorylation and ATP regeneration system |
-
2022
- 2022-04-28 CN CN202210459067.6A patent/CN115074376B/en active Active
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110041910A (en) * | 2009-10-16 | 2011-04-22 | 경상대학교산학협력단 | A echerichia coli comprising a polynucleotide encoding psicose 3-epimerase and method of producing psicose using the same |
US20170298400A1 (en) * | 2014-10-01 | 2017-10-19 | Industry-Academic Cooperation Foundation Gyeongsang National University | Method for producing psicose |
US20180273994A1 (en) * | 2014-11-06 | 2018-09-27 | Industry-Academic Cooperation Foundation Gyeongsang National University | Method for preparing psicose |
WO2017002978A1 (en) * | 2015-07-02 | 2017-01-05 | 協和発酵バイオ株式会社 | Method for producing rare sugar |
CN107723307A (en) * | 2017-10-09 | 2018-02-23 | 中国科学院天津工业生物技术研究所 | A kind of method and its application for efficiently preparing the epimerase of D psicoses 3 |
US20210254031A1 (en) * | 2018-01-25 | 2021-08-19 | Tianjin Institute Of Industrial Biotechnology, Chinese Academy Of Sciences | Engineered strain for producing allulose and derivatives thereof, method for construction therefor and use thereof |
WO2019144944A1 (en) * | 2018-01-25 | 2019-08-01 | 中国科学院天津工业生物技术研究所 | Engineering strain for producing psicose and derivatives thereof, construction method therefor and application thereof |
CN110079488A (en) * | 2018-01-25 | 2019-08-02 | 中国科学院天津工业生物技术研究所 | A kind of engineered strain producing psicose, construction method and application |
CN111712570A (en) * | 2018-01-25 | 2020-09-25 | 中国科学院天津工业生物技术研究所 | Engineering strain for producing allulose and derivatives thereof, and construction method and application thereof |
CN113474463A (en) * | 2019-03-01 | 2021-10-01 | 科汉森母乳低聚糖股份有限公司 | Fermentative production of carbohydrates by using microbial cells that mix raw materials |
US20220145342A1 (en) * | 2019-03-01 | 2022-05-12 | Chr Hansen Hmo Gmbh | Fermentative production of carbohydrates by microbial cells utilizing a mixed feedstock |
CN112080453A (en) * | 2020-08-28 | 2020-12-15 | 天津科技大学 | Genetic engineering bacterium for synthesizing D-psicose and construction method and application thereof |
CN112501224A (en) * | 2020-11-26 | 2021-03-16 | 北京化工大学 | Method for biosynthesizing D-allose by using D-glucose |
CN113005132A (en) * | 2021-03-12 | 2021-06-22 | 江南大学 | New sourced D-psicose-3-epimerase gene and application method thereof |
CN113801833A (en) * | 2021-09-08 | 2021-12-17 | 福州大学 | Recombinant bacterium single-cell factory for producing D-psicose and construction and application thereof |
CN114350727A (en) * | 2022-01-18 | 2022-04-15 | 广西大学 | Method for synthesizing D-psicose by combining phosphorylation and ATP regeneration system |
Non-Patent Citations (1)
Title |
---|
QIANG GUO 等: "Engineering Escherichia coli for D-allulose production from D-fructose by fermn", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 69, pages 13578 - 13585 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115976134A (en) * | 2022-10-21 | 2023-04-18 | 福州大学 | Method for realizing efficient synthesis of D-psicose by temperature-controlled fermentation of recombinant escherichia coli based on confinement effect |
CN116042684A (en) * | 2023-01-30 | 2023-05-02 | 态创生物科技(广州)有限公司 | Coli and application thereof in catalytic synthesis of psicose |
CN116042684B (en) * | 2023-01-30 | 2023-10-27 | 态创生物科技(广州)有限公司 | Coli and application thereof in catalytic synthesis of psicose |
Also Published As
Publication number | Publication date |
---|---|
CN115074376B (en) | 2023-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11920173B2 (en) | Fermentative production of N-acetylneuraminic acid | |
CN115074376B (en) | Method for efficiently synthesizing D-psicose by utilizing recombinant escherichia coli fermentation | |
WO2018205563A1 (en) | Method for producing tetrahydropyrimidine by fermenting recombinant corynebacterium glutamicum | |
TW201839140A (en) | A composition for producing tagatose and methods for producing tagatose using the same | |
US11180785B2 (en) | Composition for producing tagatose and method of producing tagatose using the same | |
CN110699310B (en) | Corynebacterium glutamicum for high yield of tetrahydropyrimidine and application thereof | |
KR101794384B1 (en) | Method for the preparation of 1,3-propanediol from sucrose | |
CN114774343B (en) | Coli engineering strain for producing 2' -fucosyllactose and application thereof | |
CN111471638B (en) | Construction and application of corynebacterium glutamicum mutant strain capable of producing L-homoserine | |
US11408017B2 (en) | Composition for producing tagatose and method of producing tagatose using the same | |
EP0934418B1 (en) | Microbial preparation of substances from aromatic metabolism/i | |
EP3336191B1 (en) | Escherichia sp. microorganism having l-tryptophan productivity and method for preparing l-tryptophan by using same | |
CN113774075B (en) | Escherichia coli genetically engineered bacterium and method for producing L-theanine by fermentation of escherichia coli genetically engineered bacterium | |
KR20210028292A (en) | Enhanced production of 2'-fucosyllactose in Corynebacterium Glutamicum through introduction of fucosyllactose transporter and opimization of GDP-L-fucose biosynthetic pathway | |
RU2678139C2 (en) | Escherichia species microorganism having l-tryptophan production capacity and method for producing l-tryptophan using same | |
CN109929786B (en) | Escherichia coli for producing tyrosine by fermentation method and construction method and application thereof | |
Guo et al. | Transporter mining and metabolic engineering of Escherichia coli for high‐level D‐allulose production from D‐fructose by thermo‐swing fermentation | |
WO2023115997A1 (en) | Recombinant corynebacterium glutamicum for producing isomaltulose, and application thereof | |
CN113957027B (en) | Genetically engineered bacterium for improving lactoyl-N-fucose yield and production method thereof | |
CN108823137B (en) | Method for improving abamectin yield and production strain | |
KR102462125B1 (en) | Biological production method of human milk oligosaccharide by cofactor engineering | |
CN117004547B (en) | Genetically engineered bacterium for synthesizing cis, cis-muconic acid from glucose as substrate and application thereof | |
KR102682476B1 (en) | Novel itaconic acid production pathway and method of itaconic acid production | |
CN113528411B (en) | Genetically engineered bacterium for producing N-acetyl-5-methoxy tryptamine, construction method and application | |
US20210292716A1 (en) | D-xylose dehydrogenase from coryneform bacteria and process for preparing d-xylonate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |